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Weekly submission of rats to active avoidance apparatus can be
considered a neurostimulation strategy, once it can improve
memory and can increase the density of receptors from different
neurotransmitter systems in brain areas related to memory. These
beneﬁts were observed in rats chronically infused with amyloid-β
peptide. In the present work it is presented that the same beneﬁt
for memory was observed in ﬁve months old transgenic mice for
Alzheimer’s disease (TG-PDGFB-APPSw,Ind). However, at this age, no
change in density of nicotinic receptors was observed.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
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ow data was
acquiredBehavioural data: Two-way shuttle-box (Ugo Basile, Comerio, Italy); quan-
tiﬁcation of receptor binding sites: MCID image analysis system (Interfoccus
Europe, UK).ata format Analyzed
xperimental factors Mice chronically infused with amyloid-β peptide and submitted weekly to
2-way shuttle-box
xperimental
featuresBehavioural data was acquired weekly in a two-way shuttle-box. The den-
sity of α7 nicotinic receptors was analyzed using autoradiography with
[125I]-α-bungarotoxin (5 nM). The autoradiography ﬁlms were analyzed
using MCID digital analysis system.ata source location Sao Paulo, Brazil
ata accessibility Data is with this article.D
Value of the data
 Attention training in a two-way shuttle box can modulate the central nervous system and improve
memory.
 Transgenic mice for Alzheimer’s disease, that normally present neuronal loss, also had their
memory improved when submitted to this strategy.
 Attention training can be used to stimulate the central nervous system and improve the behavior of
other animal models of central diseases.
 At ﬁve months of age, these animals did not present a change in the density of α7 nicotinic
receptors, there are known to be involved in neuroprotection.1. Data
Rats and mice infused with amyloid-β (Aβ) peptide presented loss in memory due to neurode-
generation of hippocampal and cortical cells [1–3]. When the animals were weekly submitted to a
two-way shuttle box (active avoidance apparatus), their memory was maintained even in the pre-
sence of the Aβ [2,3]. This strategy also increased the density of α7 nicotinic receptors in brain areas
related to memory, like cortex, hippocampus and amygdala [3]. The participation of the α7 nicotinic
receptors in the maintenance of memory by the submission of animals to the active avoidance
apparatus was conﬁrmed in C57Bl/6 mice submitted to the same protocol and also infused with the
α7 nicotinic receptors antagonist methyllycaconitine (paper in preparation). In the present work, the
same protocol was applied to ﬁve months old transgenic mice for Alzheimer's disease and the same
improvement in behavior was observed. However, no increase in the density of α7 nicotinic receptors
was observed in this animal model at this age.
1.1. Behavioral data
Animals were weekly stimulated in the active avoidance (two-way) shuttle-box during six weeks.
In the ﬁrst two weeks, transgenic mice showed 40.6% and 45.4%, respectively, less conditioned
avoidance responses (CAR) than WT control animals (Fig. 1). Along the stimulation process, the
animals showed an increase in CAR percentage, getting similar to the WT behavior.
1.2. Quantiﬁcation of α7 nicotinic receptors
The presence of α7 nicotinic cholinergic receptors was veriﬁed in many brain areas. In the pyr-
amidal cells of hippocampus (Py), in the CA1 and in the molecular layer of the dentate gyrus (MoDG)
no difference between WT and TG animals was veriﬁed. The same was veriﬁed in the amygdala.
However, a signiﬁcant reduction in α7 density in TG animals was veriﬁed in the granular layer of the
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Fig. 1. Conditioned avoidance responses of transgenic mice during the six weeks stimulation in active avoidance shuttle-box.
Data are means7SEM.
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Fig.2. Speciﬁc binding of [125I]-α-BUTX to α7 nicotinic cholinergic receptor in the hippocampal areas and in the amygdala
(Amyg) of the different animal groups. Data are presented as means7SEM.* Po0.05.
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animals, when compared to WT animals (7.9070.36 fmols/mg and 13.0378.92 fmols/mg, respec-
tively, Figs. 2 and 3).2. Experimental design, materials and methods
2.1. Animals
Male hemizygous transgenic mice, with ﬁve months of age-here called TG-B6.Cg-Tg (PDGFB-
APPSwInd)-that express a mutant form of the human amyloid precursor protein (hAPP) carrying the
Swedish (K670N, M671L) and Indiana (V717F) familial Alzheimer's disease mutations directed by the
platelet-derived growth factor (PDGF) β-chain promoter (APP mice, J20 line) were used as the animal
model of neurodegeneration. These mice present loss of synaptic terminals and neuronal bodies at
four months of age. Also, at this age they present loss in neuronal function with no senile plaques
deposition. The plaques deposition can be observed when animals are 8–10 months of age [4,5]. Age-
matched wild type litter mates-here called WT-were provided from our own colony, using breeding
males acquired from “The Jackson Laboratories”, USA (Stock Number 006293). Mice were kept in
controlled room temperature (22–24 °C) and humidity (55–65%), with food and water ad libitum in a
12-h-light/dark cycle. All the surgery and care procedures were strictly performed according to the
Fig. 3. Pseudocolor photomicrographs of autoradiograms representing anatomical distribution of total binding sites for α7
nACh receptor in the pyramidal cells, CA1, molecular (MoDG), granular (GrDG) and plymorphic (PoDG) layers of dentate gyrus
and amygdala (amyg) of C57Bl/6 (A, B) and transgenic (D, E) mice. Non-speciﬁc binding sites are represented in panels C and F.
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Animals (National Institute of Health Publication number 86-23, Bethesda, MD) and The Ethics
Committee on Experimental Research from Faculdade de Ciencias Medicas da Santa Casa de Sao
Paulo, Brazil. All efforts were made to minimize the number of animals used and their level of
suffering.2.2. Behavioral tests
The active avoidance apparatus was used to evaluate memory evocation and also to stimulate the
alert and sustained attention of the animals. Animals were selected according to their ability to learn
and memorize a task [1]. For this purpose, a two-way shuttle-box (Ugo Basile, Comerio, Italy) con-
sisting of two compartments accessible to each other by a hole in the wall was used. Each animal was
placed individually and then acclimated to the shuttle-box apparatus for 5 min before each session.
The animal was then subjected to 50 trials of avoidance conditioning (acquisition test). Each trial
consisted of 6 s conditioned stimulus (CS), i.e., a buzzer (70 dB, 760 Hz) and light, followed by a 4 s
unconditioned stimulus (UCS), a scramble shock of 0.5 mA delivered through ﬂoor grid. Each trial was
separated by ﬁxed intertrial intervals (20 s). During the acquisition session the number of conditioned
avoidance responses (CAR), in which the animals moved to the other compartment of the shuttle-box
before the beginning of the UCS, was recorded. All tests were carried out during the light phase
(9:00–16:00 h). All animals were submitted weekly to the same experimental protocol during six
consecutive weeks.
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After the behavioral protocols, animals were anesthetized and killed by decapitation. The brains
were removed and immediately frozen in dimethylbutane and maintained at -80oC until the use.
Serial sections of brains (20 μm) were cut on a cryostat chamber (20 °C to 22 °C, Microm HM
505 N, Francheville, France), thaw-mounted on gelatin-coated slides, desiccated for 5 min at room
temperature and kept at-80 °C until use. Sections were brought to room temperature (22 °C) and air
dried (5–10 min). Incubations were conducted for 90 min at room temperature using 5 nM [125I]-α-
bungarotoxin ([125I]-BUTX, 143.2 Ci/mmol). This concentration of radioligand was based on previous
studies in the rat brain (data not shown) and corresponds to the Bmax value. Speciﬁc binding of the
toxin for α7 nAChR, in this concentration, accounted for 80.2% of the total binding. Non-speciﬁc
binding was assessed using 2 mM of the unlabeled toxin. The radioligand was diluted in 50 mM
phosphate buffer containing 1 mM ethilenediethil-tetra-acetic acid (EDTA) and 1 mM phenyl-methil-
sulphonyl ﬂuoride (PMSF), pH 7.4. At the end of the incubation period, slides were sequentially
transferred through four rinses of 4 min each in the same buffer at 4 °C and rapidly dipped into cold
distilled water to remove excess salts. Sections were air-dried and juxtaposed against Hyperﬁlm-MP
(double-coated, 2430 cm2, Amersham Biosciences GE Healthcare, Uppsala, Sweden) for 14 days
(room temperature), along with autoradiographic [125I] micro scales (20 mm, Amersham Biosciences
GE Healthcare). The ﬁlms were developed in D-19 Kodak developer and ﬁxed in Kodak Ektaﬂo
solution.
2.4. Quantiﬁcation of receptor binding sites
The autoradiograms were quantiﬁed densitometrically using the MCID image analysis system
(Interfoccus Europe, UK). For each specimen, α7 receptors binding sites were measured on 6-12
sections. The speciﬁc binding was determined by subtracting the non-speciﬁc binding from the total
binding of adjacent sections.
2.5. Statistical analysis
Data were expressed as means7S.E.M. Behavioral data was analyzed using two-way repeated
measusers ANOVA followed by Bonferroni’s multiple comparisons test. Autoradiography data was
analyzed by unpaired Student's-t test between WT and TG data of each brain area. Only probability
values (P) less than 0.05 were considered statistically signiﬁcant.Acknowledgments
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